Compounded GLP-1 medications like semaglutide are injected once weekly in the fatty layer under the skin of the stomach, thigh, or upper arm
10.2337/diacare.29.01.06.dc05-0776
Driven by factors such as dietary changes and increasing obesity, the global diabetes epidemic continues to rise, with projections indicating an increase to 853 million people (12.96% prevalence) by 2050 ( In a key neuropathological investigation, Reske-Nielsen et al
Diabetes Obes Metab 25:19321941 Knop FK, Aroda VR, Do Vale RD et al (2023) Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
The 1-methylnicotinamide product of NNMT may itself have biological activities (including potential insulin resistance-promoting effects), and reducing its production through NNMT inhibition may contribute to metabolic improvements
In long-term trials, it is also necessary to take samples regularly to determine various quality indicators of semaglutide and observe the changes in drug quality over time
